The European Commission has now announced six new calls for funding under the Cancer Mission. The following two are particularly relevant for researchers at The Faculty of Medicine:<\/p>\n
Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer<\/a>\u00a0HORIZON-MISS-2024-CANCER-01-05. 6 MIO EUR per project. The focus should be exclusively on adolescent and young adult (AYA, age range 15-39) cancer patients and survivors.<\/p>\n Application Deadline:\u00a018 September 2024\u00a0<\/strong><\/p>\n \u00a0<\/strong>If these topics sound interesting, please contact the research advisers at MED for advise on how to build or join a consortium and apply: <\/strong>Application Support for External Funding | Faculty of Medicine | UiB<\/a><\/strong><\/p>\n \u00a0<\/strong>You can also join the EU Info Days on 25 and 26 April to learn more about the calls: Events | The research and innovation community platform (europa.eu)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" The European Commission has now announced six new calls for funding under the Cancer Mission. The following two are particularly relevant for researchers at The Faculty of Medicine: Accessible and affordable tests to advance early detection of heritable cancers in…<\/p>\n
\nAccessible and affordable tests to advance early detection of heritable cancers in European regions<\/a>\u00a0HORIZON-MISS-2024-CANCER-01-03. Innovation action 12 MIO EUR per project. To validate easy-to-use, affordable and accessible genetic, multi-omics or other biomarker-based cancer tests for early detection of cancers with an underlying heritable genetic risk. Activities are expected to achieve TRL 5 to 7 by the end of the project. \u200b\u200b\u200b\u200b\u200b\u200b\u200b<\/p>\n